Arye Rosenstein
About Arye Rosenstein
Arye Rosenstein is a Principal Architect at IntegriChain, specializing in systems integration and data migration with expertise in various programming languages. He has a strong background in the pharmaceutical and biotechnology sectors and holds an MBA and a B.Sc in Information Systems Engineering from Technion.
Work at IntegriChain
Arye Rosenstein has been serving as Principal Architect at IntegriChain since 2016. In this role, he applies his extensive knowledge of programming languages and frameworks to enhance the company's technological infrastructure. His responsibilities include overseeing system integration and data migration projects, ensuring that the solutions align with the needs of clients in the pharmaceutical and biotechnology sectors.
Education and Expertise
Arye Rosenstein holds an MBA from the Technion - Israel Institute of Technology, where he studied from 2003 to 2005. He also earned a B.Sc in Information Systems Engineering from the same institution, completing his studies from 1997 to 2001. Additionally, he has pursued further education at UC Berkeley Extension, broadening his knowledge in relevant fields. His expertise spans various programming languages, including Groovy, Grails, Ruby, Java, and Python.
Background
Prior to his current position, Arye Rosenstein gained valuable experience in various roles. He worked as a Programmer/Analyst for the Israel Defense Forces from 2002 to 2005. He then served as a Senior Analyst at McKesson for one year and as a Senior Technical Consultant at Mindlance Life Sciences from 2007 to 2011. From 2012 to 2015, he was a Solution Architect at Cumberland Consulting Group, further developing his skills in systems integration and data migration.
Achievements
Throughout his career, Arye Rosenstein has demonstrated a strong proficiency in performance tuning and technical design, which has contributed to the efficiency of enterprise web applications. He has worked with notable clients in the pharmaceutical and biotechnology sectors, including Novartis, Genentech, and Roche. His deep understanding of government pricing and Medicaid systems has been instrumental in delivering tailored solutions for healthcare industry clients.